Onco-neural antibodies and tumour type determine survival and neurological symptoms in paraneoplastic neurological syndromes with Hu or CV2/CRMP5 antibodies (Q37148508)
Jump to navigation
Jump to search
scientific article published on 17 October 2008
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Onco-neural antibodies and tumour type determine survival and neurological symptoms in paraneoplastic neurological syndromes with Hu or CV2/CRMP5 antibodies |
scientific article published on 17 October 2008 |
Statements
1 reference
Onco-neural antibodies and tumour type determine survival and neurological symptoms in paraneoplastic neurological syndromes with Hu or CV2/CRMP5 antibodies (English)
1 reference
J Honnorat
1 reference
S Cartalat-Carel
1 reference
D Ricard
1 reference
J Ph Camdessanche
1 reference
A F Carpentier
1 reference
V Rogemond
1 reference
F Chapuis
1 reference
M Aguera
1 reference
E Decullier
1 reference
A M Duchemin
1 reference
F Graus
1 reference
J C Antoine
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference